Aspirin May Reduce Ovarian Cancer Risk

JUNE 11, 2014
Women who take aspirin regularly may be at a reduced risk for ovarian cancer, the results of a meta-analysis suggest. The study, published online on February 6, 2014, in the Journal of the National Cancer Institute, analyzed data from population-based studies to help determine the association between the use of aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, and acetaminophen and the risk of developing ovarian cancer. The results indicated that regular aspirin use was associated with a reduced risk of ovarian cancer. Among 7 studies that reported frequency of use, daily use of aspirin was associated with a 20% decrease in ovarian cancer risk. In 3 studies that included dose information, low-dose aspirin use (less than 100 mg per day) was associated with a 34% reduction in ovarian cancer risk.

SHARE THIS SHARE THIS
0
 

The Oncology Care Pharmacist in Health-System Pharmacy 
According to the National Cancer Institute, almost 40% of men and women will be given a diagnosis of some form of cancer in their lifetime.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.